Skip to content

Clinical trials

Phase 1/2 Dermatitis, Atopic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 1/2 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20071
20081
20091
20121
20151
20172
20191
20201
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)3
Amytrx Therapeutics, Inc.1
Anesiva, Inc.1
Hill Dermaceuticals, Inc.1
Inmagene LLC1
Kaken Pharmaceutical1
Pfizer1
Shionogi1
Siolta Therapeutics, Inc.1
UCB Biopharma SRL1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic15
Eczema3
Skin Diseases2
Alopecia1
Dermatitis1
Hypersensitivity, Immediate1
Immune System Diseases1
Lymphoma, T-Cell, Cutaneous1
Mycosis Fungoides1
Psoriasis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.